Grace Intasa-Ard Soontaree, Birault Albane
School of Molecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology, Rayong, Thailand; Institute for Integrated Cell-Material Sciences-Vidyasirimedhi Institute of Science and Technology Research Center, Institute for Advanced Study, Kyoto University, Kyoto, Japan.
Institute for Integrated Cell-Material Sciences, Institute for Advanced Study, Kyoto University, Kyoto, Japan.
Enzymes. 2019;46:129-160. doi: 10.1016/bs.enz.2019.09.001. Epub 2019 Oct 25.
The current chapter highlights the use of chorioallantoic membrane (CAM) of fertilized chicken egg for the characterization of nanoparticles applied in cancer nanomedicine. The CAM assay represents a promising alternative to mouse models in term of costs, ease of use, rapidity and ethical issues in particular for the screening of nanoformulations. Hence, the features of nanoparticles including blood retention, biocompatibility, active targeting or tumor accumulation, angiogenic activity, drug delivery and tumor elimination might be simply evaluated via the CAM model. In particular, in this model, embryo organs and morphology, CAM vasculature and blood cells, transplanted tumors on CAM were typically monitored and used for the evaluation of the nanomaterials. With the above advantages, the CAM assay, as highly valuable in vivo model, could be used regularly in pharmaceutical industries.
本章重点介绍了利用受精鸡蛋的绒毛尿囊膜(CAM)来表征应用于癌症纳米医学的纳米颗粒。就成本、易用性、速度以及尤其是在纳米制剂筛选方面的伦理问题而言,CAM检测是小鼠模型的一种有前景的替代方法。因此,纳米颗粒的特性,包括血液滞留、生物相容性、主动靶向或肿瘤蓄积、血管生成活性、药物递送和肿瘤消除,都可以通过CAM模型简单地进行评估。特别是在这个模型中,胚胎器官和形态、CAM脉管系统和血细胞、CAM上移植的肿瘤通常会受到监测,并用于评估纳米材料。凭借上述优势,CAM检测作为一种极具价值的体内模型,可在制药行业中经常使用。